Confronto
Melanotan II vs. Octreotide
Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.
Identità
Categoria
Ricerca (altro)
Ricerca (altro)
N. CAS
121062-08-6
83150-76-9
Peso molecolare
1024.18 g/mol
1019.24 g/mol
Emivita
1 h
1.7 h
Sequenza
Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr(ol)Meccanismo d'azione
Melanotan II
Melanotan II binds non-selectively to all five melanocortin-receptor subtypes (MC1R-MC5R). Via MC1R in melanocytes, eumelanin synthesis is stimulated (pigmenting effect). Via MC4R and MC3R in the CNS, appetite, sexual function and blood pressure are modulated. The cyclic structure and D-amino acids increase stability compared to natural α-MSH.
Octreotide
Octreotide is a cyclic octapeptide that selectively binds somatostatin-receptor subtypes SSTR2 and SSTR5. Via G-protein-coupled signalling, adenylyl cyclase is inhibited, reducing the secretion of multiple hormones (growth hormone, IGF-1, glucagon, insulin, VIP, serotonin). Structural stabilisation via a disulfide bridge and D-amino acids extends the half-life relative to natural somatostatin (minutes to several hours).
Base di evidenze
Evidenza più alta
Studio sull'uomo
RCT sull'uomo
Studi
9
5
di cui sull'uomo
5
4
Effetti registrati
4
3
Contraddizioni aperte
1
1
Eventi avversi documentati
6
2
Stato legale
Voci complete
Frequently asked questions
- What is the difference between Melanotan II and Octreotide?
- Melanotan II is classified as "Ricerca (altro)", while Octreotide is classified as "Ricerca (altro)". Melanotan II: Cyclic hepta-peptide and non-selective melanocortin-receptor agonist. Originally researched at the University of Arizona as a sun-protection concept — never approved as a medicine. Widespread on the black market; regulatory warnings for cardiovascular and oncological risks. Octreotide: Synthetic octapeptide somatostatin analog with a longer half-life than endogenous somatostatin. FDA- and EMA-approved since the 1980s for acromegaly and neuroendocrine tumours. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Melanotan II or Octreotide?
- The highest available evidence level is "Studio sull'uomo" for Melanotan II and "RCT sull'uomo" for Octreotide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Melanotan II and Octreotide in Germany and the United States?
- Germania: Melanotan II — Non approvato, Octreotide — Su prescrizione. Stati Uniti: Melanotan II — Non approvato, Octreotide — Su prescrizione. These are factual summaries with source and review date on the individual pages.